Eli Lilly and Company - Retained Earnings

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Retained-Earnings" stands at 22.25 Billion United States Dollars as of 09/30/2025, the highest value at least since 03/31/2011, the period currently displayed.

As of the end of Eli Lilly and Company's third quarter, the item "Retained Earnings" stands at 22.25 Billion USD. This represents an increase of 28.06 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 63.29 percent compared to the value the year prior.
The 1 year change in percent is 63.29.
The 3 year change in percent is 122.38.
The 5 year change in percent is 211.04.
The 10 year change in percent is 32.01.

The Serie's long term average value is 13.17 Billion United States Dollars. It's latest available value, on 09/30/2025, is 68.90 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2019, to it's latest available value, on 09/30/2025, is +415.32%.
The Serie's change in percent from it's maximum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is 0.0%.